Headline
The latest stories from AHA Today.
The Health Resources and Services Administration Federal Office of Rural Health Policy today awarded $161.5 million in Coronavirus Aid, Relief and Economic Security Act funding to help rural hospitals and communities respond to the COVID-19 emergency.
Battelle is adding nine processing sites for decontaminating compatible N95 and equivalent respirators for reuse by health care personnel, bringing the total states served to 15 and Washington, D.C.
Due to the COVID-19 emergency, the Centers for Medicare & Medicaid Services will give hospitals until July 1, 2021 to implement admission, discharge and transfer notification requirements once its final rule on interoperability and patient access is published in the May 1 Federal Register.
The Senate approved by voice vote the Paycheck Protection Program and Health Care Enhancement Act – a $484 billion COVID-19 relief package – which includes an additional $75 billion for hospitals, health systems and other health care providers
The AHA is running ads in Axios newsletters to highlight hospitals and health systems efforts in response to COVID-19.
he Centers for Disease Control and Prevention updated its FAQs on COVID-19 laboratory testing and reporting. Topics include accessing laboratory testing, data and reporting, serology testing and ordering supplies.
Clinicians who participate in a clinical trial for a drug or biological product to treat a patient with novel coronavirus may now earn credit in the Merit-based Incentive Payment System, the Centers for Medicare & Medicaid Services announced.
The Bipartisan Policy Center released a new report examining the immense challenges facing the U.S. rural health care system as highlighted by the COVID-19 pandemic.
Hospitals’ already thin margins plunged into the red in March as non-emergency procedures and revenues fell and expenses for staff, supplies and building capacity rose to prepare for a surge in COVID-19 patients, according to a new report by health care consultancy Kaufman Hall.
The Food and Drug Administration authorized the first diagnostic test with a home collection option for COVID-19.